Fernando Fervenza
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Daratumumab in Treatment of PGNMID and C3 GN (NCT03095118) | Fernando Fervenza | 2017-09-07 |
Track Fernando Fervenza automatically
Every clearance here is in the API, with alerts when new ones post.